Skip to main content

Advertisement

Fig. 4 | Orphanet Journal of Rare Diseases

Fig. 4

From: Neural stem cells for disease modeling of Wolman disease and evaluation of therapeutics

Fig. 4

rhLAL reduces lysosomal staining and lipid accumulation in WD NSCs. a LysoTracker (green) and nuclear (blue) staining of rhLAL treated NSCs. b Nile red (green) and nuclear (blue) staining of rhLAL treated NSCs. c Quantitation of LysoTracker staining. d Quantitation of Nile red staining. Data are displayed as mean ± SD. Statistical significance was determined by comparing each rhLAL concentration treatment to vehicle treatment in the same WD cell line

Back to article page